Calix, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Carl Russo, a Director and 10% owner of Calix, Inc, sold 75,000 shares of common stock on July 27, 2026 for $36.20 per share.
NYSE
Calix, Inc. Director Carl Russo acquired 15,999 stock options with an exercise price of $36.05, vesting over four years starting June 29, 2026.
NYSE
Director Christopher J. Bowick was granted 4,967 restricted stock units as part of the Calix, Inc. director compensation policy.
NYSE
Calix, Inc. director Michael J. Berry was granted 4,967 restricted stock units as part of the company's non-employee director equity compensation policy.
NYSE
Director Rajatish Mukherjee was granted 4,967 restricted stock units as part of the Calix, Inc. non-employee director equity compensation policy.
NYSE
Calix, Inc. director Wade Oosterman was granted 4,967 restricted stock units as part of the company's non-employee director compensation policy.
NYSE
Director Kevin Peters transferred 126,028 shares of Calix common stock to an irrevocable trust and received an RSU grant.
NYSE
Calix, Inc. director Kathleen M. Crusco was granted 4,967 restricted stock units as part of the company's director compensation policy.
NYSE
Director Carl Russo acquired 4,967 restricted stock units as part of the company's non-employee director equity compensation policy.
NYSE
Calix, Inc. director Kira Makagon was granted 4,967 restricted stock units as part of the company's non-employee director equity compensation policy.
NYSE
Calix, Inc. Director Carl Russo reported the sale of 25,000 shares of common stock, valued at approximately $1.8 million, executed under a pre-arranged trading plan.
NYSE
Calix Director and 10% Owner Carl Russo acquired 10,000 shares of common stock through the exercise of stock options at $12.63 per share.
NYSE
Calix Director and 10% Owner Carl Russo sold 25,000 shares of common stock for approximately $1.18 million under a pre-arranged 10b5-1 trading plan.
NYSE
Calix, Inc.'s Chief Financial Officer, Cory Sindelar, exercised stock options to acquire 27,000 shares of common stock at $5.05 per share.
NYSE
Calix Director and 10% owner Carl Russo exercised options to acquire 10,000 shares of common stock at $12.63 per share.
NYSE
Carl Russo, a Director and 10% Owner of Calix, Inc., acquired 11,663 employee stock options with an exercise price of $53.59.
NYSE
Calix Director and 10% Owner Carl Russo exercised options to acquire 10,000 shares of common stock at $12.63 per share, increasing his direct beneficial ownership.
NYSE
Calix Director and 10% Owner Carl Russo exercised options to acquire 10,000 shares of common stock at $12.63 per share, increasing his direct beneficial ownership.
NYSE
Calix Chief Product Officer Shane Eleniak exercised stock options and subsequently sold 24,000 shares of common stock for a significant gain.
NYSE
Calix CFO Cory Sindelar exercised stock options and subsequently sold a portion of the acquired common stock under a pre-arranged trading plan.
NYSE
Calix Chief Product Officer Shane Eleniak exercised stock options and subsequently sold 50,000 shares of common stock on November 4, 2025.
NYSE
Calix, Inc. Director and 10% Owner Carl Russo reported the sale of 419,990 shares and the exercise of 200,000 stock options, resulting in a net reduction of his total beneficial ownership.
NYSE
Calix President & CEO Michael Weening executed options and sold a significant number of common shares in late October and early November 2025, pursuant to a Rule 10b5-1 trading plan.
NYSE
Calix, Inc.'s Chief Financial Officer, Cory Sindelar, executed pre-planned transactions, exercising stock options and selling common stock.
NYSE
Calix Director and 10% Owner Carl Russo was granted 10,329 stock options with an exercise price of $61.38, vesting annually over four years.
NYSE
Calix President & CEO Michael Weening sold a total of 176,000 shares of common stock in September 2025, following the exercise of stock options, as part of a pre-arranged 10b5-1 trading plan.
NYSE
Calix President & CEO Michael Weening exercised stock options and subsequently sold 24,000 shares of common stock for $60 per share under a Rule 10b5-1 plan.
NYSE
Calix President and CEO Michael Weening exercised stock options and subsequently sold 126,000 shares of common stock under a pre-arranged trading plan.
NYSE
Calix CFO Cory Sindelar exercised stock options and sold an equal number of shares under a pre-arranged 10b5-1 trading plan.
NYSE
Calix Inc. President and CEO Michael Weening acquired 305 shares of common stock through the company's Employee Stock Purchase Plan at a price of $33.6855 per share.